权益产品飘香新发市场

Group 1 - Recent inflows into the A-share market are accelerating through equity funds, with a notable increase in new fund launches since September, including several funds that ended their fundraising early due to high demand [1][2] - The market is experiencing a structural uptrend, with investors showing increased risk appetite and focusing on sectors like innovative pharmaceuticals and artificial intelligence, which are expected to attract ongoing capital inflows [1][3] - Over 40 funds have announced early closures in September, primarily equity funds, with frequent mentions of terms like "Hang Seng," "innovative pharmaceuticals," "technology," and "growth" in their names [2][3] Group 2 - The total fundraising scale for newly launched funds in September has exceeded 120 billion yuan, with over 140 funds established during this period [3] - Fund managers are increasingly purchasing their own newly launched products, indicating a recovery in the new fund issuance market and growing interest from individual investors [4] - The current market environment is characterized by improving liquidity and a positive economic outlook, with recommendations to focus on sectors with rising industry prosperity [4][5] Group 3 - The technology sector, particularly artificial intelligence and innovative pharmaceuticals, is expected to perform well, while cyclical sectors may lag in the short term but could recover as the economy improves [5] - There is a distinction between A-share and Hong Kong stock technology sectors, with A-shares focusing more on hard technology like semiconductors, while Hong Kong stocks are leaning towards soft technology applications [5]